IGHE and rheumatoid arthritis: Immunologic analyses demonstrated changes in JCP-specific IgE and IgG<sub>4</sub> consistent with SLIT exposure.<h4>Conclusion</h4>In this small cohort, SLIT for JCP was well tolerated and associated with potential clinical and immunologic benefits in patients with stable RA receiving immunosuppressive therapy.